Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
Titel:
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
Auteur:
Gurwith, Marc Lock, Michael Taylor, Eve M Ishioka, Glenn Alexander, Jeff Mayall, Tim Ervin, John E Greenberg, Richard N Strout, Cynthia Treanor, John J Webby, Richard Wright, Peter F